Michelle M. Cummins
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE).
Journal: JTO clinical and research reports
Published: September 18, 2024
Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.
Journal: Cell reports. Medicine
Published: December 26, 2023
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue.
Journal: Future oncology (London, England)
Published: September 28, 2023
Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.
Journal: Translational oncology
Published: July 10, 2023
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.
Journal: BMJ (Clinical research ed.)
Published: November 17, 2022
Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial.
Journal: BMJ open
Published: January 26, 2022
Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2021
Isolation and detection of microRNA from the egg of chickens.
Journal: BMC research notes
Published: March 16, 2016
Wongabel rhabdovirus accessory protein U3 targets the SWI/SNF chromatin remodeling complex.
Journal: Journal of virology
Published: November 14, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026